The decline appears to be linked to Congress killing a plan to bring samples from Mars back to Earth.

Abbott Labs stock hit a 52-week low after an earnings miss, but CEO Robert Ford isn't flinching. Here is why his $2 million ...

IDEXX beat earnings and revenue estimates, boosted by strong pet diagnostics growth, and forecast solid 2026 results as new ...

Through the first nine months of 2025, the company generated $422 million in revenue -- representing an increase of 39% year ...

Rocket Lab (RKLB)’s stock surged 45%, driven not only by a robust 10% increase in revenue but also by a significant 36% ...

Mars Sample Return would have turbo-charged Rocket Lab's revenue and added a feather to its cap.

Rocket Lab investors weigh mixed news from a successful recent launch and an issue during testing of its upcoming Neutron ...

With the S&P 500 up 16.4% and the Nasdaq Composite up 20.4% across the stretch, Rocket Lab benefited from a bullish backdrop for growth stocks. The company's share price also saw big gains in ...

Rocket Lab (NASDAQ:RKLB) disclosed last night that qualification testing of the Stage 1 tank for its Neutron medium-lift ...

Rocket Lab trades at an elevated 79x sales, making current share purchases unattractive given profitability timelines. Read ...

I know, I know. I've spent the last few months arguing that Rocket Lab -- while a superb space business and a leader in both high-tech rocketry and satellite development -- is also a very loftily ...

Planet Labs stock surges following a government contract with Slovenia. Discover how this deal impacts the company's future.